Affymax Files $100M Mixed Securities Shelf
Biopharmaceutical company Affymax Inc. filed a $100 million mixed securities shelf registration with the U.S. Securities and Exchange Commission on Friday, hoping to use the proceeds of the sale for the...To view the full article, register now.
Already a subscriber? Click here to view full article